I am a board-certified pathologist and an internationally recognized leader in hematopathology, the branch of pathology concerned with diseases of the blood and of hematopoietic and lymphoid tissue. My current research interests include lymphoma, plasma cell disorders, and diagnostic techniques for hematopathology such as cytogenetic analysis, genomics, and proteomics. My previous work has contributed much to the understanding of the histogenesis of lymphomas, MALT lymphomas, and T cell lymphomas in particular.
Read more Read less
Hematopathology is a new service established jointly under the Departments of Laboratory Medicine and Pathology, encompassing all diagnostic and academic activities of hematopathology in both departments. As service chief, I am responsible for orchestrating the integration of diagnostic results across multiple laboratories to enhance patient care and for helping to foster increased primary and collaborative research related to hematologic malignancies treated at Memorial Sloan Kettering.
Before joining Memorial Sloan Kettering, I was a professor of pathology at the Mayo Clinic, in Rochester, Minnesota, where I also served as an attending consultant pathologist, medical director of immunostains and the clinical proteomics laboratory, and vice chair of the Division of Anatomic Pathology. Before that, I spent fours years as an attending pathologist and professor of hematopathology at University College London. I was actively involved in the education and training of residents and fellows at UCL, and developed a new curriculum and accompanying textbook in pathology for undergraduate medical students.
- Clinical Expertise: Hematopathology: lymphomas, plasma cell disorders, clinical applications of proteomics.
- Languages Spoken: English
- Education: MD, Hacettepe University Medical School (Turkey); PhD in Immunology, University of London (UK)
- Residencies: Hacettepe University Medical School; University College London Hospitals
- Fellowships: University College London Hospitals
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more